Clinical Scorecard: Assessment of Oral Mucositis in High-Dose Chemotherapy Patients: A Multicenter Evaluation of Interrater Reliability Between Specialized Dentists and Registered Nurses

At a Glance

Key Highlights

• OM affects up to 80% of patients receiving HDCT prior to HSCT, typically developing within the first week post-chemotherapy
• WHO oral toxicity scale (grades 0-4) is widely used for OM assessment combining clinical findings and symptoms
• Interrater reliability between specialized dentists and nurses assessing OM showed moderate agreement (ICC=0.672)

Guideline-Based Recommendations

Diagnosis

• Use WHO oral toxicity scale for standardized OM grading
• Perform systematic intraoral examination at multiple sites (buccal, palatal mucosa, lips, floor of mouth, tongue, gingiva)
• Combine patient-reported symptoms with clinical findings for comprehensive assessment

Management

• Administer conditioning chemotherapy and supportive care per institutional protocols
• Provide analgesics including intravenous opioids for severe oral pain
• Use infection prophylaxis during cytopenia following HDCT

Monitoring & Follow-up

• Conduct OM assessments three times weekly (Monday, Wednesday, Friday) from admission until OM resolution or day +28 post-HSCT
• Train both dental specialists and nursing staff in OM assessment to ensure consistency
• Document highest OM grade per patient for clinical decision-making

Risks

• Severe OM can impair alimentation and increase analgesic requirements
• Variability in assessment reliability may affect clinical management decisions
• Non-selective chemotherapy agents increase risk of mucosal damage

Patient & Prescribing Data

Adults with multiple myeloma or lymphoma receiving HDCT prior to HSCT

High-dose melphalan for multiple myeloma and BEAC or BEAM regimens for lymphoma are standard conditioning therapies; supportive care includes granulocyte-colony stimulating factors and infection prophylaxis

Clinical Best Practices

• Calibrate and train both dentists specialized in orofacial medicine and nursing staff in OM assessment using validated scales
• Perform regular, systematic OM assessments at multiple intraoral sites to capture severity accurately
• Use a multidisciplinary approach for OM management integrating symptom control and supportive care
• Ensure documentation and data capture are standardized and validated for clinical trials and routine care

Related Resources & Content

• World Health Organization oral toxicity scale
• High-dose chemotherapy regimens BEAC and BEAM
• Granulocyte-colony stimulating factor (Filgrastim) use in HSCT